Indication
Chronic Kidney Disease Requiring Chronic Dialysis
3 clinical trials
3 products
Product
Oxylanthanum CarbonateClinical trial
A Multicenter, Multidose, Study to Assess the Tolerability and Pharmacokinetics of Oxylanthanum Carbonate at Clinically Effective Doses in Patients With Chronic Kidney Disease on DialysisStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
Randomized Open-Label Study to Evaluate Tenapanor as the Core Therapy in the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Who Are Phosphate Binder Naive or on Phosphate Binders to Optimize Phosphorus ManagementStatus: Completed, Estimated PCD: 2021-10-13
Product
TenapanorClinical trial
Lumasiran in Hyperoxalaemic Patients on HaemodialysisStatus: Not yet recruiting, Estimated PCD: 2024-11-30
Product
Lumasiran